• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H2受体拮抗剂法莫替丁、洛替丁、雷尼替丁和L-643,441对大鼠离体胃黏膜的抗分泌作用概况。

The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.

作者信息

Reeves J J, Stables R

出版信息

Agents Actions. 1987 Feb;20(1-2):22-8.

PMID:2883848
Abstract

Four H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 were tested against gastric secretory concentration-response curves to histamine, methacholine and dibutyryl cyclic AMP (dbcAMP) on the rat isolated gastric mucosa. All four drugs inhibited the secretory response to histamine, but the nature of this H2-receptor antagonism differed according to the drug. Ranitidine and famotidine were competitive, fully surmountable antagonists of histamine, but loxtidine and L-643,441 were unsurmountable antagonists. At high concentrations, the H2-receptor antagonists caused a small inhibition of the secretory response to methacholine but had no effect on the secretory response to dbcAMP. The rat isolated gastric mucosa is a useful preparation for characterisation of the antisecretory effects of H2-receptor antagonists.

摘要

对四种H2受体拮抗剂法莫替丁、洛替丁、雷尼替丁和L-643,441进行了测试,观察它们对大鼠离体胃黏膜上组胺、乙酰甲胆碱和二丁酰环磷腺苷(dbcAMP)的胃分泌浓度-反应曲线的影响。所有这四种药物均抑制对组胺的分泌反应,但这种H2受体拮抗作用的性质因药物而异。雷尼替丁和法莫替丁是组胺的竞争性、完全可克服的拮抗剂,但洛替丁和L-643,441是不可克服的拮抗剂。在高浓度时,H2受体拮抗剂对乙酰甲胆碱的分泌反应有轻微抑制作用,但对dbcAMP的分泌反应无影响。大鼠离体胃黏膜是表征H2受体拮抗剂抗分泌作用的有用标本。

相似文献

1
The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.H2受体拮抗剂法莫替丁、洛替丁、雷尼替丁和L-643,441对大鼠离体胃黏膜的抗分泌作用概况。
Agents Actions. 1987 Feb;20(1-2):22-8.
2
Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.长期服用H2拮抗剂不会改变胃对组胺的分泌反应,也不会改变舒法替丁的抗分泌活性。
Aliment Pharmacol Ther. 1990;4 Suppl 1:7-13.
3
Isolated gastric mucosa: an early approach to the study of the mechanism of action of gastric antisecretory agents.离体胃黏膜:研究胃抗分泌药物作用机制的早期方法。
Methods Find Exp Clin Pharmacol. 1989 Oct;11(10):621-34.
4
Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.雷尼替丁、法莫替丁和奥美拉唑对大鼠血浆胃泌素的急性影响。
J Pharmacol Exp Ther. 1989 Apr;249(1):1-5.
5
[Gastric acid secretion and histamine H2 receptor antagonists].[胃酸分泌与组胺H2受体拮抗剂]
Gastroenterol Clin Biol. 1990;14(12):982-94.
6
Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.H2受体拮抗剂法莫替丁对大鼠的抗分泌及抗溃疡作用:与雷尼替丁的比较。
Br J Pharmacol. 1987 Sep;92(1):153-9. doi: 10.1111/j.1476-5381.1987.tb11307.x.
7
Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.依罗替丁的组胺H2受体拮抗作用。对大鼠胃酸分泌、胃泌素水平及非甾体抗炎药诱导的胃毒性的影响。
Arzneimittelforschung. 1997 Apr;47(4A):439-46.
8
Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.新型H2拮抗剂YM-11170对清醒犬的抗分泌作用动力学
Eur J Pharmacol. 1983 Aug 5;91(4):371-6. doi: 10.1016/0014-2999(83)90160-7.
9
Comparative effects of H2-receptor antagonists on drug interaction in rats.H2受体拮抗剂对大鼠药物相互作用的比较效应。
Drug Metab Dispos. 1986 Nov-Dec;14(6):649-53.
10
[Effect of a new H2 receptor antagonist, famotidine, on gastric secretion].新型H2受体拮抗剂法莫替丁对胃酸分泌的作用
Boll Soc Ital Biol Sper. 1986 Sep 30;62(9):1103-9.

引用本文的文献

1
Proceedings of the British Pharmacological Society. Nottingham, 7th-9th September 1988. Abstracts.英国药理学会会议记录。诺丁汉,1988年9月7日至9日。摘要
Br J Pharmacol. 1988 Dec;95 Suppl(Suppl):715P-910P.
2
Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.法莫替丁。对其药效学和药代动力学特性以及在消化性溃疡疾病和其他相关疾病中的治疗用途的最新综述。
Drugs. 1989 Oct;38(4):551-90. doi: 10.2165/00003495-198938040-00005.
3
Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease.
组胺H2受体拮抗剂与前列腺素在消化性溃疡疾病治疗中的比较
Drugs. 1989 Apr;37(4):391-401. doi: 10.2165/00003495-198937040-00001.